Prevention of spontaneous neu-expressing mammary tumor development in mice transgenic for rat proto-neu by DNA vaccination
- 1 January 2001
- journal article
- Published by Springer Science and Business Media LLC in Gene Therapy
- Vol. 8 (1), 75-79
- https://doi.org/10.1038/sj.gt.3301360
Abstract
At the forefront of medicine, Gene Therapy brings you the latest research into genetic and cell-based technologies to treat disease. It also publishes Progress & Prospects reviews and News and Commentary articles, which highlight the cutting edge of the field.Keywords
This publication has 24 references indexed in Scilit:
- p185neu protein is required for tumor and anchorage-independent growth, not for cell proliferation of transgenic mammary carcinomaInternational Journal of Cancer, 2000
- Role of HER2 gene overexpression in breast carcinomaJournal of Cellular Physiology, 2000
- DNA vaccination against the ovarian carcinoma-associated antigen folate receptor α (FRα) induces cytotoxic T lymphocyte and antibody responses in miceCancer Gene Therapy, 1999
- Molecular and immunological analysis of genetic prostate specific antigen (PSA) vaccineOncogene, 1998
- Increased expression of c-erbB-2 in hormone-dependent breast cancer cells inhibits cell growth and induces differentiationOncogene, 1998
- Vaccination against tuberculosis by DNA injectionNature Medicine, 1996
- Intramuscular immunisation withMUC1 cDNA can protect C57 mice challenged with MUC1-expressing syngeneic mouse tumour cellsInternational Journal of Cancer, 1996
- Identification of an immunodominant peptide of HER-2/neu protooncogene recognized by ovarian tumor-specific cytotoxic T lymphocyte lines.The Journal of Experimental Medicine, 1995
- Genetic immunization is a simple method for eliciting an immune responseNature, 1992
- Selection of monoclonal antibodies which induce internalization and phosphorylation of P185HER2 and growth inhibition of cells with HER2/neu gene amplificationInternational Journal of Cancer, 1991